focus -WSS

focus

author：Wikipedia 2025-09-28 23:47:49 - browse：744

John Crowley pictured with his daughter Megan Crowley — health policy news from STAT — John Crowley pictured with his daughter Megan. Crowley family

WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday.

Crowley came to biotech when his children were diagnosed with a rare genetic neuromuscular disease. He started working at Bristol Myers Squibb, and started Novazyme, which was eventually successful in creating an enzyme replacement therapy for Pompe disease. He later started and worked for several different biotech companies, most recently with Amicus Therapeutics, which had a drug approved to treat the disease in September.

The trade association’s board chair, Ted Love, served on the board of the company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： What to expect at HLTH 2023, the health care industry conference

explore

WSS

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

The thinking behind the controversial eating disorder chatbot Tessa

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Bristol 'take

Xenotransplantation trials will require adjusting expectations, experts say

A public health expert passes on football's full body collisions for youths

focus

focus

hotspot

Virginia high school admissions case could be legal follow

FDA rejects Alnylam's heart disease treatment over insufficient data

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

In Memoriam: Notable people who died in 2023

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

What does generative AI mean for health care? We asked experts

Why age limits for politicians are a terrible idea

Novavax promises a turnaround & Lilly roils the obesity market

Liquid biopsy for lung cancer is launched by Delfi

entertainment

Biden administration plans revamp of organ transplant system

What to expect at HLTH 2023, the health care industry conference

Analysis of telehealth claims data suggest service duplication

Biden administration plans revamp of organ transplant system

FDA panel signals lack of confidence in Amgen cancer drug data

Phenylephrine and the overlooked value of the placebo effect

explore

knowledge

focus

focus